Yestino - The Signal ยท Germany Merck KGaAhttps://yestino.com/entities/germany-merck-kgaa-78b87eEvery event involving Germany Merck KGaAenGermany's Merck KGaA is buying U.K. gene-silencing biotech for $1.3 billionhttps://yestino.com/events/germany-s-merck-kgaa-is-buying-u-k-gene-silencing-biotech-fo-0469b3https://yestino.com/events/germany-s-merck-kgaa-is-buying-u-k-gene-silencing-biotech-fo-0469b3Mon, 19 Oct 2026 13:24:00 GMTThe all-cash deal adds divesiran, an experimental rare-disease drug ready for late-stage trials, to Merck's pipeline Sources: Quartz